影像诊断与介入放射学
影像診斷與介入放射學
영상진단여개입방사학
JOURNAL OF DIAGNOSTIC IMAGING AND INTERVENTIONAL RADIOLOGY
2014年
3期
258-262
,共5页
伯小皖%郑曙光%徐辉雄%郭乐杭%孙丽萍%卢峰%刘琳娜%刘畅
伯小皖%鄭曙光%徐輝雄%郭樂杭%孫麗萍%盧峰%劉琳娜%劉暢
백소환%정서광%서휘웅%곽악항%손려평%로봉%류림나%류창
超声引导%双极射频消融%肝癌
超聲引導%雙極射頻消融%肝癌
초성인도%쌍겁사빈소융%간암
Ultrasound-guided%Bipolar radiofrequency ablation%Liver cancer
目的:观察超声引导经皮双极射频消融治疗肝癌的局部疗效。方法选取我院2012年5月~2013年10月收治、以治愈性治疗为目的的24例肝癌患者32个病灶,对所有患者均采取超声引导下经皮双极射频消融进行治疗,术后1个月观察患者影像学(超声造影、增强CT或增强MRI)检查结果,以评价局部疗效,以后每3个月随访一次,以观察患者复发情况。结果病灶完全消融(CA)率96.9%(31/32),其中最大径<3cm病灶CA率为100%(27/27),最大径≥3cm病灶CA率为80%(4/5);原发性肝癌完全CA率95.7%(22/23),转移性肝癌CA率100%(9/9)。所有患者均未出现严重并发症及与手术相关的死亡。随访2~19个月,局部复发率为6.3%(2/32)远处复发率为33.3%(8/24)。结论超声引导下经皮双极射频消融治疗肝癌安全可靠、局部疗效确切,对小肝癌尤其明显。
目的:觀察超聲引導經皮雙極射頻消融治療肝癌的跼部療效。方法選取我院2012年5月~2013年10月收治、以治愈性治療為目的的24例肝癌患者32箇病竈,對所有患者均採取超聲引導下經皮雙極射頻消融進行治療,術後1箇月觀察患者影像學(超聲造影、增彊CT或增彊MRI)檢查結果,以評價跼部療效,以後每3箇月隨訪一次,以觀察患者複髮情況。結果病竈完全消融(CA)率96.9%(31/32),其中最大徑<3cm病竈CA率為100%(27/27),最大徑≥3cm病竈CA率為80%(4/5);原髮性肝癌完全CA率95.7%(22/23),轉移性肝癌CA率100%(9/9)。所有患者均未齣現嚴重併髮癥及與手術相關的死亡。隨訪2~19箇月,跼部複髮率為6.3%(2/32)遠處複髮率為33.3%(8/24)。結論超聲引導下經皮雙極射頻消融治療肝癌安全可靠、跼部療效確切,對小肝癌尤其明顯。
목적:관찰초성인도경피쌍겁사빈소융치료간암적국부료효。방법선취아원2012년5월~2013년10월수치、이치유성치료위목적적24례간암환자32개병조,대소유환자균채취초성인도하경피쌍겁사빈소융진행치료,술후1개월관찰환자영상학(초성조영、증강CT혹증강MRI)검사결과,이평개국부료효,이후매3개월수방일차,이관찰환자복발정황。결과병조완전소융(CA)솔96.9%(31/32),기중최대경<3cm병조CA솔위100%(27/27),최대경≥3cm병조CA솔위80%(4/5);원발성간암완전CA솔95.7%(22/23),전이성간암CA솔100%(9/9)。소유환자균미출현엄중병발증급여수술상관적사망。수방2~19개월,국부복발솔위6.3%(2/32)원처복발솔위33.3%(8/24)。결론초성인도하경피쌍겁사빈소융치료간암안전가고、국부료효학절,대소간암우기명현。
Objective To observe the local therapeutic efficacy of ultrasound-guided percutaneous bipolar radiofrequency ablation for liver cancer.Methods 24 patients with 32 liver tumor nodules who were referred to our hospital from May,2012 to October,2013.All patients were treated with ultrasound-guided percutaneous bipolar radiofrequency ablation with curative intention. We Observed the local therapeutic efficacy of all patients within one month after the treatment.The imageological examination (Contrast-enhanced ultrasound,contrast-enhanced Computed Tomography or contrast-enhanced magnetic Resonance Imaging) were used to decide the local therapeutic efficacy.We obeserved the recurrence of the tumors through the follow-up of every three months.Results Complete ablation(CA)was achieved in 96.9%(31/32)of tumor nodules.The CA rate was remarkably higher in nodules ≤3 cm(100%,27/27)than that in nodules >3 cm(80%,4/5)(P<0.05).CA rate was 95.7%(22/23)for primary liver cancers and 100%(9/9)for metastatic liver cancers.There was no mortality associated with bipolar radiofrequency ablation. Patients were followed-up from 2-19 months.The local recurrence rates were 6.3%(2/32)and the distant recurrence rates were 33.3%(8/24).Conclusion Ultrasound-guided percutaneous bipolar radiofrequency ablation for liver cancer is a safe and effective method, especially for small liver cancers.